Cossu M - Search Results

1

Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis.

Carvalheiro T, Marut W, Pascoal Ramos MI, García S, Fleury D, Affandi AJ, Meijers AS, Giovannone B, Tieland RG, Elshof E, Ottria A, Cossu M, Meizlish ML, Veenendaal T, Ramanujam M, Moreno-García ME, Klumperman J, Liv N, Radstake TRDJ, Meyaard L. Carvalheiro T, et al. Among authors: cossu m. J Autoimmun. 2024 May 1;146:103219. doi: 10.1016/j.jaut.2024.103219. Online ahead of print. J Autoimmun. 2024. PMID: 38696927 Free article.

2

Fostemsavir to overcome drug-drug interactions in heavily treatment-experienced people with HIV and cancer.

Giacomelli A, Cattaneo D, Pozza G, Moschese D, Cossu MV, Dalu D, Gervasoni C. Giacomelli A, et al. Among authors: cossu mv. J Antimicrob Chemother. 2024 Apr 25:dkae121. doi: 10.1093/jac/dkae121. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38661237 No abstract available.

3

Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.

d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. J Antimicrob Chemother. 2024 Apr 6:dkae081. doi: 10.1093/jac/dkae081. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38581349

4

Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV.

Cossu MV, D'Avolio A, Gervasoni C, Giacomelli A, Cattaneo D, Moschese D. Cossu MV, et al. Antimicrob Agents Chemother. 2024 May 2;68(5):e0017524. doi: 10.1128/aac.00175-24. Epub 2024 Mar 27. Antimicrob Agents Chemother. 2024. PMID: 38534104 No abstract available.

5

Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals.

Cossu MV, Cattaneo D, Moschese D, Giacomelli A, Soloperto S, D'Avolio A, Antinori S, Gori A, Rizzardini G, Gervasoni C. Cossu MV, et al. J Antimicrob Chemother. 2024 May 2;79(5):1126-1132. doi: 10.1093/jac/dkae080. J Antimicrob Chemother. 2024. PMID: 38530862

6

Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge.

Avey S, Chatterjee M, Manyakov NV, Cooper P, Sabins N, Mosca K, Mori S, Baribaud F, Morris M, Lehar J, Deiteren A, Cossu M, Smets S, Huizer T, Lamousé-Smith E, Campbell K, Pandis I. Avey S, et al. Among authors: cossu m. Clin Transl Sci. 2024 Feb;17(2):e13734. doi: 10.1111/cts.13734. Clin Transl Sci. 2024. PMID: 38380580 Free PMC article.

7

Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study.

Borgonovo F, Lovaglio PG, Mariani C, Berta P, Cossu MV, Rizzardini G, Vittadini G, Capetti AF. Borgonovo F, et al. Among authors: cossu mv. BMJ Open. 2024 Feb 6;14(2):e075185. doi: 10.1136/bmjopen-2023-075185. BMJ Open. 2024. PMID: 38320835 Free PMC article.

8

Detection and typization of HPV genotypes in subjects with oral and upper respiratory tract lesions, Milan, Italy.

Rizzo A, Salari F, Eplite A, Giacomelli A, Moschese D, Dalu D, Cossu MV, Lorusso R, Pozza G, Morelli L, Fasola C, Tonielli C, Fusetti C, De Cristofaro V, Gori A, Lombardi A, Rizzardini G, Gismondo MR, Antinori S. Rizzo A, et al. Among authors: cossu mv. Infect Dis (Lond). 2024 Apr;56(4):293-298. doi: 10.1080/23744235.2024.2303020. Epub 2024 Jan 13. Infect Dis (Lond). 2024. PMID: 38217420

9

High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy.

Rizzo A, Moschese D, Salari F, Giacomelli A, Morelli L, Cossu MV, Fusetti C, Petri F, Casalini G, Poloni A, Lazzarin S, Gori A, Antinori S, Gismondo MR, Lombardi A, Rizzardini G. Rizzo A, et al. Among authors: cossu mv. J Med Virol. 2024 Jan;96(1):e29370. doi: 10.1002/jmv.29370. J Med Virol. 2024. PMID: 38197518

10

Initial experience with robot-assisted ureteroscopy with Ily® Robot.

Fiori C, Cossu M, Poggio M, Quarà A, Di Dio M, De Luca S, Checcucci E, Manfredi M, Amparore D, Porpiglia F. Fiori C, et al. Among authors: cossu m. Minerva Urol Nephrol. 2023 Dec;75(6):761-765. doi: 10.23736/S2724-6051.23.05572-6. Minerva Urol Nephrol. 2023. PMID: 38126287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

515 results

Search Page